Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Immunological Senescence Phenotype as a Resistance Profile to Pembrolizumab in Patients With Relapsed/Refractory Hodgkin's Lymphoma

IRCCS Azienda Ospedaliero-Universitaria di Bologna · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
pembrolizumab
hodgkin lymphoma, pembrolizumab, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 833297
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.